You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.
To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.
Donor‐Derived Infections
Publication Date: April 1, 2019
Last Updated: March 14, 2022
Recommendations
Risk mitigation
All donors should have medical and social histories obtained to identify individuals at increased risk of transmitting HIV, HBV, and HCV. (Low, Strong)
317067
NAT should be used to test all donors for HCV and in increased risk donors for HIV and HBV. Interpretation of the residual risk of undiagnosed infection in NAT negative donors needs to be contextualized with when the testing was performed relative to the eclipse period post‐exposure. (Low, Strong)
317067
In living donors, donor testing should be done as soon as practically possible before donation but no later than 28 days prior to organ recovery. Living donors should also be screened for relevant endemically limited infections based on exposure history of the individual donor. (Low, Strong)